Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02764255Completed

Embryoscope and Reproductive Outcome

Role: lead

NCT02457377Not ApplicableCompleted

Laparoscopic Transabdominal Cerclage: New Approach

Role: lead

NCT02568488Phase 4Completed

The Effect of Metformin on Different Hormones in PCOS Patients

Role: lead

NCT03081754Completed

Correlation of Uterine and Umbilical Arteries Doppler With Placental Pathology in IUGR

Role: lead

All 4 trials loaded